DeepMind is the name of a British artificial intelligence that was acquired by Google in 2014. The system has been used to study breast cancer detection methods and the results are encouraging. Recently, an AI model has been developed that enables cancer to be identified so efficiently that it outweighs the effectiveness of specialists.
Note that breast cancer is the most common cancer among women. Detection is difficult and potentiates the error, which can lead to misdiagnosis.
For this case, the company trained artificial intelligence with a dataset from British and US patients and was able to reduce the number of false positive cases by 5.7% and false negative cases by 9.4% during one year. testing phase in some US hospitals. In the United Kingdom the reductions were 1.2% and 2.7% respectively.
Unlike medical specialists, who used patient histories and past mammograms to make their diagnoses, AI used only the most recent mammogram for each patient.
The AI team underlines that this is an early stage of research and that further testing will be required before the system is ready for global use. DeepMind has been previously tested in other medical projects, including eye disease and liver problems.